Connecting Companies with Top-Tier Research Institutions

• Facilitating partnerships with Japan’s 800+ universities, national tech hubs, and labs such as AIST, RIKEN and NIMS. RIKEN alone maintains over 260 international MOUs, and finding the right principal investigator without insider knowledge is a genuine needle-in-a-haystack problem we solve for you.
• Direct access to Japan’s government-backed R&D programs, including NEDO’s SBIR Promotion Program (Phase 1 grants up to ¥20M at 100% funding, Phase 2 up to ¥100M at two-thirds coverage), the Moonshot R&D Program, and the Eureka Globalstars framework spanning 15 partner countries.
• Strategic matchmaking between industry leaders and researchers, mapping specific labs and PIs to your exact technical needs. With ¥1.065 trillion flowing through 32,093 active university–industry joint projects, precise targeting — not broad outreach — is what wins partnerships.

Creating Synergistic R&D Collaborations

• Co-development of innovative technologies through joint research agreements, entrusted research, and consortium membership — structured to respect the project governance and milestone expectations that Japanese institutions hold and that differ sharply from Western models.
• Funding assistance & grants for collaborative projects, including NEDO’s ¥2 trillion Green Innovation Fund, the JST CREST/PRESTO programs (¥150–500M for CREST teams), and stacked incentives that can reduce net collaboration costs by 40–60%.
• Intellectual property strategy & legal consultation under Japan’s new framework, which requires foreign entities to share at least 50% of IP rights generated from government-funded R&D and mandates prior notification before transferring ownership or granting exclusive licenses.

Ensuring Seamless R&D Operations in Japan

• Navigation of Japan’s complex regulatory environment, where PMDA pharmaceutical approval pathways run two to three years longer than FDA or EMA equivalents and differ fundamentally from METI industrial certification and green-energy utility rules.
• Compliance with industry standards & government regulations, including export controls, data governance, and the detailed expenditure documentation that government-funded projects demand — where non-compliance can disqualify you from future funding.
• Streamlined patent application and approval processes that meet Japanese Patent Office laboratory-notebook standards, with particular care for biologics sequences and the employee-invention compensation rules unique to Japan.

Turning Research into Marketable Solutions

• Go-to-market strategy for new technologies, tuned to Japanese distribution expectations and keiretsu dynamics that foreign companies rarely understand intuitively, so research outputs actually reach revenue.
• Market feasibility analysis & commercialization planning, informed by the fact that university-originated startups more than doubled to 3,782 between FY2016 and FY2022 — even as commercialization success still lags behind U.S. and European benchmarks.
• Licensing & strategic partnership development through university Technology Licensing Organizations (TLOs) such as Tohoku Techno Arch and UTokyo IPC, plus innovation-box incentives offering a 30% deduction on qualified AI patent income developed in Japan.

Facilitating Seamless International Cooperation

• Training on Japanese business culture for foreign R&D teams, covering nemawashi (informal consensus building) and ringi-sei (circular written approval) — the practices behind an estimated 57% of failed international R&D partnerships, where communication, not technology, is the killer.
• Enhancing communication & workflow in cross-border projects, aligning reporting cadences with Japan’s April–March fiscal and academic calendars and the Obon and New Year holiday periods that shape every timeline.
• On-site support for overseas teams in Japan, including live cultural mediation during joint research — attending lab meetings, translating intent as well as language, and flagging misunderstandings before they escalate into abandoned partnerships.

A Top-Three Global R&D Power, Now Opening Its Doors

• Japanese universities received approximately ¥5,313 billion (~$35B) in FY2024 — the highest in five years and up 12.6% year over year.
• University–private company joint research reached ¥1.065 trillion across 32,093 active projects, while entrusted research grew 17.0% year over year.
• New IP regulations now allow direct funding of foreign entities under programs like Moonshot, with researchers in the U.S., Australia, France and Finland already receiving Japanese government grants.

Why Insider Access Is Everything

• RIETI analysis shows 13% of Japanese inventions are co-inventions and 28% involve other external cooperation — over 40% involve outside parties, almost all with partners they already trust.
• Corporate funding into university research runs at roughly one-fourth the level seen in Germany, so pathways must be built through relationship capital, not standardized portals.
• Cultural misalignment — not technical shortcomings — causes an estimated 57% of failed international R&D partnerships involving Japanese institutions.

Sector Momentum You Can Plug Into

• University-originated startups more than doubled to 3,782 between FY2016 and FY2022, signaling a maturing commercialization ecosystem.
• Japan’s AI market is projected to grow from $6.2 billion to $90 billion by 2035, while the national biostrategy targets ¥53.3 trillion in bio-manufacturing by 2030.
• Automotive companies installed about 13,000 industrial robots in 2024 (+11% YoY), and NEDO’s ¥2 trillion Green Innovation Fund anchors decarbonization R&D.